Neuroblastoma Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Funding
• Clinical Trials
• Forums

TAA06 Injection in the Treatment of Patients With B7-H3-positive Relapsed/ Refractory Neuroblastoma
Condition:   B7-H3-positive Relapsed/ Refractory Neuroblastoma Intervention:   Biological: T cell injection targeting FLT3 chimeric antigen receptor Sponsor:   PersonGen BioTherapeutics (Suzhou) Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 30, 2022 Category: Research Source Type: clinical trials